U-Yohimbe ungumthi onesiqhelo okhulayo entshona eAfrika eNigeria, eCameroon, eCongo naseGabon. I-bark yomthi iqukethe iimpawu ezisebenzayo ezibizwa ngokuba yi-alkaloids. Inqununu ye-alkaloid ibizwa ngokuthi yohimbine.
I-Yohimbine yinyango yesigqirha e-United States ukwenzela unyango lwe-erectile dysfunction. Udumo lwayo luye lwadlula ukususela kwi- Viagra .
I-Yohimbe bark extracts nazo zithengiswa kwiivenkile zokutya kunye ne-intanethi. EJamani, ayivunyelwe ukusetyenziswa. I-Yohimbe ingabangela ukunyuka okuyingozi kwixinzelelo legazi, kunye nokuxhalaba kunye nezinye iziphumo.
Igama lesiLatini lomgubo uYohmbe nguPausinystalia yohimbe .
Kutheni Abantu Basebenzisa Yohimbe?
Ngokwesiko, uJohimbe wasetyenziselwa eAfrika ngenxa yomkhuhlane, ukukhwehlela, iqhenqa, kunye ne-aphrodisiac. Okwangoku, ubungqina bobunzululwazi obuxhasa uxanduva lweJohimbe lusekho.
1) Ukungasebenzi kwe-Erectile
I-Yohimbe bark icatshulwa ngokubanzi kwi-intanethi nakwiindawo zokutya ezempilo njenge- aphrodisiac yemvelo yokwandisa i-libido kunye nokunyangwa kwe-erectile disys function. Nangona kunjalo, akukho bubungqina bokubonisa ukuba izongezo zeemfuyo ziyasebenza. Uninzi lwezifundo zekliniki zijonge i-yohimbine yonyango kwaye ayiyiyo i-Yohimbe yemveliso yamanzi.
Izifundo malunga nokusebenza kwe-yohimbine ziye zafumana iziphumo eziphikisanayo. Ngokwe-organic erectile dysfunction (i-erectile dysfunction ngenxa yengxaki engokwemvelo), olunye uphando olungalawulwayo luye lwafumanisa ukuba i-yohimbine inenzuzo kumadoda ane-organic erectile dysfunction.
Olunye uphando lufumanise ukuba aluphumelelanga ngaphezu kwe-placebo.
Isifundo saseJamani sihlolisise ukuba i-30 mg / imini ye-yohimbine kwiiveki ezi-4 iza kunceda amadoda ane-erectile ukungasebenzi ngenxa yengxaki yenyama. I-Yohimbine itholakala ukuba iyasebenza ngakumbi kune-placebo (71% vs 45%).
2) Ukulahlekelwa kwesisindo
I-Yohimbine ifunyenwe kuphando lokuqala lokwandisa i-lipolysis ngokunyusa ukukhululwa kwe-norepinephrin etholakale kwiiseli ezinamafutha nokuvimbela ukusetyenziswa kwe-alpha-2 receptor.
Nangona kunjalo, uphando olulawulwayo lufumene ukuba i-43 mg / ngosuku uYohumbe ayinaso umphumo kwisisindo somzimba, isalathisi somzimba, umzimba weoli, ukusabalalisa amafutha kunye namazinga e-cholesterol.
3) Uxinzelelo
U-Yohimbe uye wakhuthazwa njengendlela yonyango yokudandatheka ngenxa yokuba ibimbela i-enzyme ebizwa ngokuthi i-monoamine oxidase. Nangona kunjalo, oku kufunyenwe kuphela kumanani aphakamileyo (ngaphezu kwama-50 mg / ngosuku), okungenakukhuseleka.
Imijelo
Nangona zixhamla iingxelo zikaJohimbe, akufanele zithathwe zinikezelwe ingozi enkulu yempilo. Kubalulekile ukuba udibane nodokotela wakho ukuba usacinga ukusebenzisa uYohimbe.
EJamani, u-Yohimbe useKhomishoni E (i-arhente ye-herbal regulatory agency) uludwe lwee-herbs ezingavumelekanga ngenxa yokukhathazeka ngokukhuseleka kwe-herb nokusebenza. EUnited States, i-FDA ineenombolo zeengxelo zokuthintela kunye nokuhluleka kwezintso emva kokusetyenziswa kweJohimbe.
I-Yohimbe ayilunconywanga ngoba ine-index ye-thrapeutic index. Kukho uluhlu oluncinci lwe-dosing-ngaphantsi kwayo, iifuno ayisebenzi kwaye ngaphezu kwayo isityalo sinetyhefu.
Imiphumo emibi yee-dosages eziqhelekileyo ingabandakanya ukungcola, isisulu, isifo, ukuxhala, ukunyamekela kwentliziyo, kunye nokunyuka kwengcinezelo yegazi.
Njengoko umzuzu omalunga no-40 mg ngosuku ungabangela iziphumo ezibi kakhulu, ezinjengeenguqu ezinobungozi begazi, ukuxilonga, ukukhubazeka, isibindi, iinjongo kunye neengxaki zeentliziyo, kwaye zi nokuba zibulale.
Ngenxa yokuba i-yohimbine inqanda i-enzyme i-monoamine oxidase, abantu abathatha u-Yohimbe kufuneka baphephe konke ukutya okutyikitya (isib. Isibindi, i-cheeses, iwayini ebomvu) kunye neemveliso ezingaphezulu kwezinto eziqulethe isithako se phenylpropanolamine, njengama-decongestants asezantsi.
Abantu abaneentsholongwane okanye isifo sesibindi, izilonda zesisu, isifo senhliziyo, uxinzelelo lwegazi oluphezulu, uxinzelelo lwegazi oluphantsi, uxinzelelo lwangemva kokukhathazeka, kunye nokuphazamiseka kwesifo akufanele kuthathe u-Yohimbe.
U-Yohimbe akufanele athathwe ngabafazi abakhulelweyo okanye abahlengikazi, abantwana okanye abantu abadala.
I-Yohimbe akufanele idibaniswe nezidakamizwa ezixinzelelekileyo ngaphandle kokuba phantsi kweliso lugqirha.
I-Yohimbe isongezelelo asizange ihlolwe ukhuseleko kwaye igcine ingqalelo ukuba ukhuseleko lwezongezelelo kwabasetyhini abakhulelweyo, oomama, abantwana kunye nalabo abanezifo zonyango okanye abathabatha imishanguzo ayilwanga. Unokufumana iingcebiso ekusebenziseni izongezo apha, kodwa ukuba ucinga ngokusetyenziswa kweJohimbe, kubalulekile ukuba uthethe nodokotela wakho kuqala.
> Imithombo:
> Guay AT et al. "Yohimbine unyango lwe-Organic Erectile Dysfunction kwi-Triose-Escalation Trial". International Journal of Impotence Research. 14.1 (2002): 25-31.
> Mann K et al. "Iimpembelelo zeJohimbine kwiZibonelelo zoSondo kunye noHlelo lwe-Penile Tumescence no-Rigidity kwi-Erectile Dysfunction". Uvimba woLuntu. 25.1 (1996): 1-16.
> Morales A et al. "Ngaba i-Yohimbine iphumelele kwiNyango ye-Organic Impotence? Iziphumo zovavanyo olulawulwayo". Umbhalo we-Urology. 137.6 (1987): 1168-72.
> I-Sax L. "Yohimbine Ayithinteli Ukusabalaliswa Kwezinto Kwabantu". I-International Journal ye-Obesity. 15.9 (1991): 561-5.
> Vogt HJ et al. "I-Double-Blind, i-Placebo-Controlled Control and Efficiency Trial ne Yohimbine Hydrochloride kwiNyango ye-Nonreganic Erectile Dysfunction". International Journal of Impotence Research. 9.3 (1997): 155-61.